Product Details of 93-97-0. In 2019 BIOORG MED CHEM LETT published article about BIOLOGICAL EVALUATION; STRUCTURAL-CHARACTERIZATION; TARGETED THERAPY; ANTICANCER; DESIGN in [Zhang, Lin-Hao; Zhang, Zhi-Hong; Li, Ming-Yue; Jin, Xue-Jun; Piao, Hu-Ri] Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Minist Educ, Coll Pharm, Yanji 133002, Peoples R China; [Wei, Zhi-Yu] Dalian Univ, Coll Med, Dalian 116622, Liaoning, Peoples R China in 2019, Cited 37. The Name is Benzoic anhydride. Through research, I have a further understanding and discovery of 93-97-0.
The hypoxia-inducible factor-la (HIF-1 alpha) pathway has been implicated in tumor angiogenesis, growth, and metastasis. Therefore, the inhibition of this pathway is an important therapeutic target for the treatment of various types of cancers. Here, we designed and synthesized 31 ursolic acid (UA) derivatives containing a tetrazole moiety and evaluated them for their potential anti-tumor activities as HIF-la transcriptional inhibitors. Of these, compound 14d (IC50 0.8 +/- 0.2 mu M) displayed the most potent activity and compounds 14a (IC50 4.7 +/- 0.2 mu M) exhibited the most promising biological profile. Analysis of the structure-activity relationships of these compounds with HIF-1 alpha suggested that the presence of a tetrazole group located at C-28 of the UA derivatives was critical for their inhibitory activities.
Welcome to talk about 93-97-0, If you have any questions, you can contact Zhang, LH; Zhang, ZH; Li, MY; Wei, ZY; Jin, XJ; Piao, HR or send Email.. Product Details of 93-97-0
Reference:
Isothiazole – Wikipedia,
,Isothiazole – ScienceDirect.com